535 filings
Page 3 of 27
CORRESP
j6m51m lndomd
23 Nov 22
Correspondence with SEC
12:00am
8-K
dpfc1y7eo7n7xt6b
22 Nov 22
Other Events
5:00pm
8-K
955xk ib0d
15 Nov 22
OncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanoma
5:06pm
8-K
whcuwbr63wtgh fpj
14 Nov 22
Other Events
6:10am
CORRESP
umt3chq
14 Nov 22
Correspondence with SEC
12:00am
8-K
z3jge
8 Nov 22
OncoSec Announces Reverse Stock Split
1:15pm
UPLOAD
e3inpqql
8 Nov 22
Letter from SEC
12:00am
8-K
5yrz7y2
17 Oct 22
Departure of Directors or Certain Officers
5:00pm
8-K
6s9q2xkz y5ewl
11 Oct 22
Departure of Directors or Certain Officers
8:00am
8-K
tdzm6ewpt aqjiag
4 Oct 22
OncoSec Announces Pipeline Prioritization and Workforce Reduction
5:28pm
8-K
4su386u
3 Oct 22
Departure of Directors or Certain Officers
5:00pm
S-8
cfhn7o
29 Jul 22
Registration of securities for employees
4:29pm
8-K
3sfwef2atvwpdwxy7syk
12 Jul 22
Submission of Matters to a Vote of Security Holders
5:21pm
8-K
9wujhx
9 Jun 22
Other Events
4:30pm
8-K
5adkb6ui15guey
3 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
DEFA14A
0gqgmfiaz8ozvm6duy
31 May 22
Additional proxy soliciting materials
4:30pm